Follow this preprint
Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
View ORCID ProfileAlejandro J. Gonzalez-Ochoa, Joseph D. Raffetto, Ana G. Hernández, Nestor Zavala, Obed Gutiérrez, Arturo Vargas, Jorge Loustaunau
doi: https://doi.org/10.1101/2020.12.04.20242073
Now published in Thrombosis and Haemostasis doi: 10.1055/a-1414-5216
Alejandro J. Gonzalez-Ochoa
1callejón 5 de mayo y calle 7 No 791, Colonia Comercial, 83449, San Luis Rio Colorado, Sonora México
2Department of Surgery, Hospital General Zona No12 Instituto Mexicano Seguro Social, Av Chihuahua y Benjamin Hill, s/n, 83439, San Luis Rio Colorado, Sonora México
MDRoles: Chief Vascular-Endovascular Surgery CLINEDEM, Chief Vascular Surgery
Joseph D. Raffetto
3Harvard University, VA Boston Healthcare System, Brigham and Women’s Hospital, Boston, MA, USA
MDRoles: Associate Professor of Surgery
Ana G. Hernández
4callejón 5 de mayo y calle 7 No 791, Colonia Comercial, 83449, San Luis Rio Colorado, Sonora, México
MDRoles: Chief Otorhinolaryngology CLINEDEM
Nestor Zavala
5Hospital General de Zona No12 Instituto Mexicano Seguro Social, Av Chihuahua y Benjamin Hill, s/n 83439, San Luis Rio Colorado, Sonora, México
MDRoles: General Director
Obed Gutiérrez
6Hospital General de Zona No12 Instituto Mexicano Seguro Social, Av Chihuahua y Benjamin Hill, s/n, 83439, San Luis Rio Colorado, Sonora, México
7Emergency Department, Hospital General, Av. Guadalupe Victoria y calle 8 s/n, 83440, San Luis Rio Colorado, Sonora, México
MDRoles: Sub-director Emergency Medicine
Arturo Vargas
8Urban Out care Center, Secretaria de Salud, Av. Guerrero y calle 32 No 3200A, 83499, San Luis Rio Colorado, Sonora, México
MDJorge Loustaunau
6Hospital General de Zona No12 Instituto Mexicano Seguro Social, Av Chihuahua y Benjamin Hill, s/n, 83439, San Luis Rio Colorado, Sonora, México
MD
Posted December 07, 2020.
Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
Alejandro J. Gonzalez-Ochoa, Joseph D. Raffetto, Ana G. Hernández, Nestor Zavala, Obed Gutiérrez, Arturo Vargas, Jorge Loustaunau
medRxiv 2020.12.04.20242073; doi: https://doi.org/10.1101/2020.12.04.20242073
Now published in Thrombosis and Haemostasis doi: 10.1055/a-1414-5216
Subject Area
Subject Areas
- Addiction Medicine (409)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3059)
- Dermatology (258)
- Emergency Medicine (458)
- Epidemiology (12991)
- Forensic Medicine (13)
- Gastroenterology (855)
- Genetic and Genomic Medicine (4797)
- Geriatric Medicine (443)
- Health Economics (748)
- Health Informatics (3042)
- Health Policy (1098)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (495)
- Neurology (4568)
- Nursing (243)
- Nutrition (675)
- Oncology (2370)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1234)
- Primary Care Research (516)
- Public and Global Health (7153)
- Radiology and Imaging (1590)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (399)
- Surgery (506)
- Toxicology (64)
- Transplantation (218)
- Urology (188)